Literature DB >> 21865550

Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells.

S Alice Long1, Mary Rieck, Megan Tatum, Paul L Bollyky, Rebecca P Wu, Isabelle Muller, Jhon-Chun Ho, Heather G Shilling, Jane H Buckner.   

Abstract

Low Ag dose promotes induction and persistence of regulatory T cells (Tregs) in mice, yet few studies have addressed the role of Ag dose in the induction of adaptive CD4(+)FOXP3(+) Tregs in humans. To this end, we examined the level of FOXP3 expression in human CD4(+)CD25(-) T cells upon activation with autologous APCs and varying doses of peptide. Ag-specific T cells expressing FOXP3 were identified by flow cytometry using MHC class II tetramer (Tmr). We found an inverse relationship between Ag dose and the frequency of FOXP3(+) cells for both foreign Ag-specific and self Ag-specific T cells. Through studies of FOXP3 locus demethylation and helios expression, we determined that variation in the frequency of Tmr(+)FOXP3(+) T cells was not due to expansion of natural Tregs, but instead, we found that induction, proliferation, and persistence of FOXP3(+) cells was similar in high- and low-dose cultures, whereas proliferation of FOXP3(-) T cells was favored in high Ag dose cultures. The frequency of FOXP3(+) cells positively correlated with suppressive function, indicative of adaptive Treg generation. The frequency of FOXP3(+) cells was maintained with IL-2, but not upon restimulation with Ag. Together, these data suggest that low Ag dose favors the transient generation of human Ag-specific adaptive Tregs over the proliferation of Ag-specific FOXP3(-) effector T cells. These adaptive Tregs could function to reduce ongoing inflammatory responses and promote low-dose tolerance in humans, especially when Ag exposure and tolerance is transient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865550      PMCID: PMC3178710          DOI: 10.4049/jimmunol.1003880

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  Multiplex mapping of CD4 T cell epitopes using class II tetramers.

Authors:  Junbao Yang; Eddie A James; Laurie Huston; Nancy A Danke; Andrew W Liu; William W Kwok
Journal:  Clin Immunol       Date:  2006-05-04       Impact factor: 3.969

Review 2.  FOXP3: not just for regulatory T cells anymore.

Authors:  Steven F Ziegler
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

3.  Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.

Authors:  Todd S Davidson; Richard J DiPaolo; John Andersson; Ethan M Shevach
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

4.  IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells.

Authors:  Song Guo Zheng; Juhua Wang; Pu Wang; J Dixon Gray; David A Horwitz
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

5.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.

Authors:  Milica Vukmanovic-Stejic; Yan Zhang; Joanne E Cook; Jean M Fletcher; Arthur McQuaid; Joanne E Masters; Malcolm H A Rustin; Leonie S Taams; Peter C L Beverley; Derek C Macallan; Arne N Akbar
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

6.  Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.

Authors:  Eddie A James; John Bui; DeAnna Berger; Laurie Huston; Michelle Roti; William W Kwok
Journal:  Int Immunol       Date:  2007-09-30       Impact factor: 4.823

7.  DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

Authors:  Udo Baron; Stefan Floess; Georg Wieczorek; Katrin Baumann; Andreas Grützkau; Jun Dong; Andreas Thiel; Tina J Boeld; Petra Hoffmann; Matthias Edinger; Ivana Türbachova; Alf Hamann; Sven Olek; Jochen Huehn
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

8.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

9.  Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

Authors:  Kristin V Tarbell; Lucine Petit; Xiaopan Zuo; Priscilla Toy; Xunrong Luo; Amina Mqadmi; Hua Yang; Manikkam Suthanthiran; Svetlana Mojsov; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-01-08       Impact factor: 14.307

10.  FOXP3 promoter demethylation reveals the committed Treg population in humans.

Authors:  Peter C J Janson; Malin E Winerdal; Per Marits; Magnus Thörn; Rolf Ohlsson; Ola Winqvist
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  21 in total

1.  Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.

Authors:  Hweixian Leong Penny; Tyler R Prestwood; Nupur Bhattacharya; Fionna Sun; Justin A Kenkel; Matthew G Davidson; Lei Shen; Luis A Zuniga; E Scott Seeley; Reetesh Pai; Okmi Choi; Lorna Tolentino; Jinshan Wang; Joseph L Napoli; Edgar G Engleman
Journal:  Cancer Immunol Res       Date:  2016-09-16       Impact factor: 11.151

2.  Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

Authors:  Michelle Rosenzwajg; Guillaume Churlaud; Roberto Mallone; Adrien Six; Nicolas Dérian; Wahiba Chaara; Roberta Lorenzon; S Alice Long; Jane H Buckner; Georgia Afonso; Hang-Phuong Pham; Agnès Hartemann; Aixin Yu; Alberto Pugliese; Thomas R Malek; David Klatzmann
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

Review 3.  The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation.

Authors:  Paul L Bollyky; Marika Bogdani; Jennifer B Bollyky; Rebecca L Hull; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

4.  Systemic immunogenicity of para-Phenylenediamine and Diphenylcyclopropenone: two potent contact allergy-inducing haptens.

Authors:  Jesper Dyrendom Svalgaard; Carina Særmark; Morten Dall; Karsten Buschard; Jeanne D Johansen; Kåre Engkilde
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

5.  The protein tyrosine phosphatase PTPN22 controls forkhead box protein 3 T regulatory cell induction but is dispensable for T helper type 1 cell polarization.

Authors:  G Fousteri; T Jofra; I Debernardis; S M Stanford; A Laurenzi; N Bottini; M Battaglia
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

6.  Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.

Authors:  Catia S Verbeke; Susana Gordo; David A Schubert; Sarah A Lewin; Rajiv M Desai; Jessica Dobbins; Kai W Wucherpfennig; David J Mooney
Journal:  Adv Healthc Mater       Date:  2017-01-24       Impact factor: 9.933

7.  The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Lisa H Shiue; Jacob Couturier; Dorothy E Lewis; Caimiao Wei; Xiao Ni; Madeleine Duvic
Journal:  Photodermatol Photoimmunol Photomed       Date:  2015-03-28       Impact factor: 3.135

8.  Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Elizabeth Randall Harsha-Strong; Richard K Burt; Syamal K Datta
Journal:  Clin Immunol       Date:  2013-08-23       Impact factor: 3.969

9.  Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.

Authors:  Michael S Turner; Kumiko Isse; Douglas K Fischer; Hēth R Turnquist; Penelope A Morel
Journal:  Diabetologia       Date:  2014-04-16       Impact factor: 10.122

10.  Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.

Authors:  Xiaoli Meng; Zaid Al-Attar; Fiazia S Yaseen; Rosalind Jenkins; Caroline Earnshaw; Paul Whitaker; Daniel Peckham; Neil S French; Dean J Naisbitt; B Kevin Park
Journal:  J Immunol       Date:  2017-04-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.